3DPOD Episode 49: Bioprinting with CELLINK Founder Dr. Hector Martinez

Share this Article

On this episode of the 3DPOD, we go into bioprinting. With us is Hector Martinez, the CTO and a co-founder of CELLINK (CLNK-B.ST). CELLINK is a bioprinting rocket ship which took off only a few years ago. A small passionate team began selling bioinks and have since grown the company into a leader in bioprinting.

CELLINK is publicly traded and has a wide array of printers from the affordable to complex machines and from extrusion to DLP and holographic machines, as well. Martinez tells us about the foundation of CELLINK and the initial teams. He also has sage advice about how to know when your co-founders are the right partners for you. He talks to us as well about the near-term opportunities in bioprinting, what he expects from the market and where he expects interesting things to happen. If you are looking to explore bioprinting or are in the industry, this is a must-listen. I’d also recommend it to entrepreneurs and people with entrepreneurial spirits. You’ll walk away jazzed and informed from this one.

Share this Article


Recent News

3D Systems Sells Medical Simulation Business for $305M

3D Printed Microneedles Make for Less Painful Continuous Glucose Monitoring



Categories

3D Design

3D Printed Art

3D Printed Food

3D Printed Guns


You May Also Like

Engineer Spent Over 900 Hours Designing and 3D Printing Miniature Roller Coaster

If it ever comes up in conversation, I will freely admit that I am a total roller coaster junkie. I love them—the higher and crazier, the better. Give me inversions,...

Featured

Direct Image Sintering: Visitech Introduces New DLP-PBF 3D Printing Tech

In fall 2020, Visitech quietly made news with the release of a scrolling DLP projector capable of sintering plastic powder, potentially opening up new levels of throughput and reduced cost...

Readily3D Bioprinting Pancreas to Help EU-Funded Program Develop Diabetes Treatment

As the World Health Organization reports, the prevalence of diabetes has been rising over the last few decades, and there are currently around 422 million people around the world who...

Sponsored

ROKIT Healthcare’s bioprinting-based diabetic foot treatment kit registered as a U.S. FDA medical device

ROKIT Healthcare has completed registration of its Dr. INVIVO-based diabetic foot treatment with the U.S. FDA and has successfully completed clinical studies in the U.S. Since 2019, the company has...


Shop

View our broad assortment of in house and third party products.